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Purpose: The goal of this research was to determine if P58IPK, a member of the Hsp40 family that inhibits eukaryotic
initiation factor 2α (eIF2α), inhibits endoplasmic reticulum (ER) stress and leads to downregulated expression of vascular
endothelial growth factor (VEGF) and decreased apoptosis in human retinal capillary endothelial cells (HRCECs).
Methods: Recombinant vectors were constructed using P58 in adeno-associated virus type 2 (rAAV2-P58 IPK) and P58
RNA in the plasmid pGIPZ (pGIPZ-P58IPK). The four experimental groups were: (1) non-transfected/non ER stressed
control;  (2)  non-transfected/ER  stressed;  (3)  rAAV2-P58IPK-transfected/ER stressed;  and  (4)  pGIPZ-  P58IPK  RNAi
transfected/ER stressed. ER stress was induced by treating cells with tunicamycin. Expression of P58IPK was determined
in transfected cells. Expressions of the following factors were assessed: vascular endothelial growth factor (VEGF), C/
EBP homologous protein (CHOP), activating transcription factor 4 (ATF4), and glucose-regulated protein 78 (GRP78).
Apoptosis levels were also determined.
Results: Significantly increased expression of P58IPK was detected in cells transfected with rAAV2-P58IPK (0.63±0.02)
as compared to those transfected with pGIPZ-P58IPK RNAi (0.23±0.01). P58IPK expression was not different between the
control transfected cells (rAAV2-GFP and pGIPZ-GFP). Following ER stress, expression levels of ATF-4, GRP78, CHOP,
and VEGF in cells overexpressing P58IPK were not different from those in unstressed control cells. This inhibitory effect
of P58IPK on the expression of ER stress-related factors was suppressed in cells transfected with pGIPZ-P58IPK RNAi.
Apoptosis was significantly increased in cells transfected with pGIPZ-P58IPK RNAi but not with rAAV2-P58IPK.
Conclusions: The study demonstrates that P58IPK inhibits ER stress and plays an important role in maintaining balance
and stability of the ER in HRCECs.
Endoplasmic reticulum (ER) stress is thought to be a
contributing  factor  underlying  many  human  diseases.  In
pathologic conditions, accumulation of unfolded or misfolded
proteins in the ER can lead to ER stress or initiate the unfolded
protein response [1,2]. If protein folding or degradation fails
to occur in response, apoptotic pathways are initiated [1].
Studies in mice have indicated that ER stress can lead to
islet cell apoptosis through induction of C/EBP homologous
protein (CHOP) and contribute to the development of diabetes
[3].  ER  stress  has  also  been  implicated  as  a  mediator  of
diabetic  retinopathy  (DR),  a  major  microvascular
complication of diabetes [4,5]. Roybal and colleagues [6]
reported that ER stress increases the expression of vascular
endothelial  growth  factor  (VEGF)  by  activating  the
transcription  factor  4  (ATF4)  pathway.  Further,  Xu  and
colleagues [7] noted that both VEGF and protein kinase C
expression were elevated in the early stages of DR using a rat
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model.  These  findings  are  significant  as  VEGF  has  been
demonstrated  to  be  involved  in  regulating  a  variety  of
pathologic  changes  associated  with  DR  including
neovascularization,  vascular  permeability,  and  thrombosis
[8]. Given the evidence linking the development of DR with
ER  stress,  it  is  pertinent  to  further  elucidate  the  precise
mechanisms/pathways  involved  so  potential  therapeutic
interventions  may  be  designed  to  treat/prevent  DR  by
inhibiting ER stress.
P58IPK,  a  member  of  the  Hsp40  family,  was  first
discovered as an inhibitor of eukaryotic initiation factor 2α
(eIF2α) [9]. Since this time, findings from several studies have
indicated that P58IPK plays an important role in ER stress
protection  [10,11].  For  instance,  Yan  and  colleagues  [11]
reported that decreases in P58IPK activity were associated with
increased  expression  of  several  ER  stress-inducible  genes
such  as  CHOP.  It  has  also  been  demonstrated  that  mice
lacking the P58IPK gene exhibit gradual onset of glycosuria,
hyperglycemia, and hypoinsulinemia [12]. The number of β-
cells in the islets of these mice was significantly reduced, and
the expressions of a variety of apoptosis-related genes were
increased. This suggests that an apoptosis pathway is activated
in the absence of P58IPK, leading to a decrease in the number of
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1122β-cells  and  loss  of  functionality.  The  ER  stress-inhibiting
effects  of  P58IPK  appear  related  to  its  capacity  to  inhibit
phosphorylation of eIF2α, which is involved in eliciting the
previously mentioned unfolded protein response [13].
To  our  knowledge,  no  study  has  examined  the
relationship between P58IPK and ER stress in cells isolated
from  human  eyes.  Characterizing  this  relationship  is
important  as  it  may  help  identify  possible  targets  for
pharmaceutical intervention (i.e., P58IPK modulation) in the
treatment/prevention of DR. In the present study, we sought
to examine the effects of P58IPK on ER stress in human retinal
capillary  endothelial  cells  (HRCECs)  by  assessing  the
expression  of  ER  stress-related  factors,  glucose-regulated
protein 78 (GRP78), ATF4, and CHOP. We also examined
the possibility that P58IPK may be able to ameliorate diabetes-
associated  blood  vessel  damage  by  assessing  changes  in
VEGF  expression  and  cellular  apoptosis.  Our  working
hypothesis  was  that  P58IPK  would  inhibit  ER  stress  in
HRCECs.
METHODS
Human  retinal  capillary  endothelial  cells  culture  and
characterization: Donor eyes (12) were obtained from the
Tongji  Hospital  Eye  Bank.  Donors  were  healthy  accident
victims with an average age of 33.5 years (consent was granted
by  the  donors’  family  members  and  experiments  were
approved by the Internal Review Board of the hospital).
The well established method for isolating and culturing
HRCECs has been previously described [14]. The donor eyes
were  cut  circumferentially  3  mm  posterior  to  the  limbus.
Retinas were then harvested and homogenized by two gentle
up/down strokes in a 15 ml Dounce homogenizer (Chuang Rui
company,  Dongguan,  China).  Collected  cells  were
resuspended in human endothelial serum-free material (SFM)
basal  growth  medium  (Gibco  Grand  Island,  NY),
supplemented with 20% fetal bovine serum (FBS), 50 U/ml
endothelial  cell  growth  factor  (Sigma-Aldrich,  St.  Louis,
MO), and 1% insulin–transferrin–selenium (Gibco, Inc. Los
Angeles,  CA).  Cells  were  cultured  and  passaged  in
fibronectin-coated dishes at 37 °C in a humidified atmosphere
containing 5% CO2. Cultured cells were then characterized for
endothelial homogeneity by testing for activity to factor VIII
antigen (von Willebrand factor), measuring acetyl-LDL (Ac-
LDL) receptors in endothelial cells, as described previously
[14], and by morphological examination by light microscopy.
Only cells from passages 3-7 were used in the experiments.
HRCECs were treated with tunicamycin (an ER stressor)
according  to  a  modification  of  the  method  described  by
Shimazawa and colleagues [15]. Cells were washed twice
with Dulbecco’s Modified Eagle Medium (DMEM; Sigma-
Aldrich) and then immersed in DMEM supplemented with 1%
FBS plus tunicamycin (2 μg/ml) for 12 h. Cell viability was
measured using a single-cell digital imaging-based method
that  stained  nuclei.  Retinal  fluorescence  intensity  was
visualized in vivo.
Construction  and  packaging  of  recombinant  adeno-
associated virus type 2- (rAAV2) P58IPK: The coding sequence
of p58IPK was obtained from the human cDNA bank/domain
and synthesized using Golden Taq (Tiangen Biotech Beijing,
China).  pSNAV-  P58IPK  plasmids  were  then  formed  after
DNA digestion and ligation. Transfection of BHK-21 cells
with pSNAV-P58IPK was performed in a 6 well plate using a
Lipofectamine 2000 kit (Invitrogen Inc, Carlsbad, CA). These
cells are hereafter referred to as BHK/P58IPK. BHK/P58IPK
cells  were  then  transferred  to  and  cultured  in  a  flask
(110x480  mm;  Wheaton  Inc,  Millville,  NJ)  before  being
infected  with  HSV1-rc/ΔUL2  (Benyuan  Zhengyang  Inc,
Beijing, China; moore=0.1) to induce rAAV2-P58IPK when the
cell number reached 8×108. The cells were detached after 48
h of culture and were then divided into Fernbach culture flasks
(250 ml) for further purification. Purified rAAV2-P58IPK was
identified by reverse-transcription polymerase chain reaction
(RT–PCR). The titer of rAAV2-P58IPK (virus genome/ml) was
assessed using in situ hybridization with a digoxin labeled
cucumber  mosaic  virus  probe  to  obtain  a  final  titer  of
1×1012.
Construction  of  pGIPZ-P58  IPK  RNAi  using  pGIPZ,  a
lentiviral shRNA cloning vector: The P58IPK RNAi (Addgene,
Inc., Cambridge, MA) sequence inserted was as follows: TGC
TGT TGA CAG TGA GCG CAG GTG CTG AAT GTG GAG
TAA ATA GTG AAG CCA CAG ATG TAT TTA CTC CAC
ATT CAG CAC CTT TGC CTA CTG CCT CGG A. pGIPZ-
green  fluorescence  protein  (GFP)  was  used  to  evaluate
transfection efficiency.
Plasmid transfection of human retinal capillary endothelial
cells:  Cultured  HRCECs  were  transfected  with  rAAV2-
P58IPK, PGIPZ-P58IPK RNAi, pGIPZ-GFP, or rAAV2-GFP.
Cells were plated in 24 well culture plates, grown overnight
to 70%-80% confluence, and then washed twice with serum-
free basal growth medium. While only rAAV2 was added to
control group wells, 10×109 copies of rAAV2- P58IPK, or
PGIPZ-  P58IPK  RNAi  were  added  to  each  well  in  the
experimental  groups.  In  addition,  plasmids  containing
rAAV2-GFP  and  pGIPZ-GFP  were  separately  added  to
HRCECs to monitor transfection efficiency.
Semi-quantitative  PCR  and  real  time  PCR  for  P58IPK
expression  in  human  retinal  capillary  endothelial  cells:
HRCECs were harvested, and RNA was extracted using the
QiagenRNA  extraction  kit  (Qiagen  Inc.,  Venlo,  The
Netherlands).  After  quantification,  RNA  was  reverse
transcribed  to  cDNA  using  the  Super  Script  II  RT  kit
(Invitrogen Inc.). Real time PCR was performed using the
Hotstar Taq Polymerase kit (Qiagen Inc.) with SYBR Green
technology (ABI Inc., Foster City, CA). GAPDH was used as
an internal control. Primers for GAPDH were as follows:
sense,  5′-CCT  GTA  CGC  CAA  CAC  AGT  GC-3′  and
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1123antisense, 5′-ATA CTC CTG CTT GCT GAT CC-3′. Primers
for P58IPK were as follows: sense, 5′-GAG GTT TGT GTT
GGG ATG CAG-3′ and antisense, 5′-GCT CTT CAG CTG
ACT  CAA  TCA  G-3′.  The  PCR  reaction  for  P58IPK  was
performed  in  a  final  reaction  volume  of  20  μl  using  the
following conditions: a preheating cycle at 95 °C for 3 min
then 31 cycles at 95 °C for 30 s, 62 °C for 30 s, and 72 °C for
30 s followed by an elongation cycle at 72 °C for 8 min.
Melting curve analysis was performed by monitoring FAM/
SYBR fluorescence.
For semi quantitative (sq) PCR, 1 μl of single-stranded
cDNA was added to a 20 μl PCR reaction mixture containing
10  pmol  of  a  gene  specific  primer  pair,  1X  PCR  buffer
(Invitrogen Inc.) containing 3μM MgCl2, 5μM dNTPs, and 1
unit of Platinum Taq (Invitrogen Inc.). PCR conditions were
as follows: initial denaturation at 95 °C for 4 min, 30 cycles
at 95°C for 30 s, 58°C for 45 s, and 72°C for 30 s, the final
elongation step was performed for 5 min at 72°C. After 30
cycles, the final elongation step was performed for 5 min.
Equal  amounts  of  PCR  products  were  separated  on  1.5%
agarose gels and visualized by ethidium bromide staining.
GAPDH was used as an internal control.
Cell  apoptosis  analysis:  There  were  a  total  of  four
experimental groups in this study: (1) a control group (no ER
stress  or  transfection);  (2)  an  ER  stress  group  (no
transfection);  (3)  a  P58IPK  transfection  (upregulation)/ER
stress group; and (4) a P58IPK RNAi (inhibition)/ER stress
group.  cellular  apoptosis  was  evaluated  using  propidium
iodide (PI) to stain the DNA. Cells were trypsinized, pelleted,
and  resuspended  in  one  volume  of  ice-cold  phosphate-
buffered saline (PBS). The suspension was gently agitated
while three volumes of ice-cold 95% ethanol were slowly
added. Cells were then pelleted and resuspended in equal
volumes of 30 μg/ml PI and 100 μg/ml RNase A (both in PBS).
Stained cells were stored overnight at 4 °C and protected from
light  until  analysis.  Flow  cytometry  was  performed  to
determine the percentage of cells in apoptosis.
Real time PCR for gene expression of VEGF, GRP78, ATF4,
and CHOP: HRCECs from each experimental group were
collected for detection of VEGF, GRP78, ATF4 and CHOP
expression. Total RNA was isolated for quantification. RNA
was then reverse transcribed to cDNA using a Super Script II
RT kit (Invitrogen Inc). Real time PCR was performed using
the Hotstar Taq Polymerase kit (Qiagen Inc.) with SYBR
Green technology (ABI Inc.). Primers for VEGF, GRP78,
ATF4, CHOP, and GAPDH are described in Table 1. The PCR
reaction was performed in a final reaction volume of 20 μl
under the following conditions: a preheating cycle at 95 °C
for 5 min then 33 cycles at 95°C for 20 s, 56°C for 30 s, and
72°C for 30 s, the final elongation step was performed for 5
min at 72°C an elongation cycle at 72 °C for 8 min. Melting
curve analysis was performed by monitoring FAM/SYBR
fluorescence.
Western  blotting:  Total  protein  was  extracted  from  the
HRCECs and quantified using bicinchoninic acid. The protein
was mixed with the loading buffer, denatured for 6 min at
60 °C, cooled, centrifuged for 5 min, and then separated by
sodium-dodecyl  sulfate  PAGE  (SDS–PAGE).  Monoclonal
anti-CHOP (Santa Cruz Biotechnology Inc., Santa Cruz, CA),
polyclonal  anti-ATF4  (Santa  Cruz  Biotechnology,  Inc.),
monoclonal anti-GRP78 (BD Biosciences, San Jose, CA),and
monoclonal anti-VEGF (Santa Cruz Biotechnology Inc.) were
used to probe the proteins. A secondary antibody (1:1000
dilution) was then applied, and the signal was revealed by
chemiluminescence.  The  same  polyvinylidene  fluoride
(PVDF) membranes were reused to detect β-actin (internal
control)  by  incubating  with  the  mouse  anti-human  actin
antibody (Gene Co., Hong Kong, China). The bands observed
on the films were analyzed by automatic image analysis, and
the integrated optical density (OPTDI) of each protein band
was normalized to the OPTDI value of the corresponding β-
actin band from the same sample.
Statistical analysis: Normally distributed data were compared
by one-way ANOVA while non-normally distributed data
were  compared  by  Kruskal–Wallis  test.  When  significant
differences  were  detected  between  groups,  multiple
comparisons of means were performed using the Bonferroni
procedure,  with  type-I  error  rate  at  a  maximum  of  0.008
(0.05/6)  adjustment.  Statistical  analyses  were  performed
using SPSS 15.0 Statistics software (SPSS Inc., Chicago, IL),
and differences were considered significant when p<0.05.
Data are presented as the mean±standard error of the mean
(SEM).
RESULTS
The transfection rate of rAAV2-P58IPK was 85% and pGIPZ-
P58IPK  RNAi  was  87%  two  days  after  transfection
(transfection rates of the P58IPK and GFP plasmids were
assumed to be equivalent). Gene expression levels of P58IPK
in  HRCECs  transfected  with  rAAV2-GFP,  pGIPZ-GFP,
TABLE 1. HUMAN RETINAL CAPILLARY ENDOTHELIAL CELLS REAL TIME PCR PRIMERS
Gene Primer (5’-3’) PCR annealing
temp (°C)
VEGF GACAAGAAAATCCCTGTGGGC 56
AACGCGAGTCTGTGTTTTTGC
GRP78 GCCTGTATTTCTAGACCTGCC 56
TTCATCTTGCCAGCCAGTTG
CHOP AGAGGAAGAATCAAAAACCTTCACT 56
ACTCTGTTTCCGTTTCCTAGTTCTT
ATF4 AGGAGTTCGCCTTGGATGCCCTG 56
AGTGATATCCACTTCACTGCCCAG
GAPDH CCTGTACGCCAACACAGTGC 56
ATACTCCTGCTTGCTGATCC
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1124rAAV2- P58IPK, or pGIPZ- P58IPK RNAi as determined by
semi-quantitative polymerase chain reaction (sq PCR) and
real  time  PCR  are  presented  in  Figure  1.  There  were
significant  differences  in  the  expression  levels  of  P58IPK/
GAPDH among the four transfection groups (p<0.001). sq
PCR  result  show  that  the  highest  level  was  in  the  group
transfected with rAAV2- P58IPK (0.63±0.02) while the lowest
was in the group with pGIPZ- P58IPK RNAi (0.23±0.01). No
significant differences in P58IPK/GAPDH levels were found
between the rAAV2-GFP and pGIPZ-GFP groups. The results
of real time PCR show that the ratio of P58IPK/GAPDH was
1.45±0.05 in the rAAV2- P58IPK group and 0.41±0.03 in the
pGIPZ- P58IPK RNAi group.
There was a statistically significant overall difference in
apoptosis levels two days after transfection (Figure 2). There
was no significant difference between groups 1 (control) and
3 (rAAV2- P58IPK). Apoptosis levels were significantly higher
in group 4 (co-transfected with pGIPZ- P58IPK RNAi and
rAAV2- P58IPK) compared to all other groups (p<0.001 for
all).
Significant  differences  in  both  gene  and  protein
expression  of  ATF4,  GRP78,  CHOP,  and  VEGF  were
apparent between the four groups as determined by real time
PCR and western blot analyses, respectively (p<0.001, see
Figure  3  and  Figure  4).  Real  time  PCR  revealed  that
expression levels of ATF4, GRP78, CHOP, and VEGF were
significantly increased in the group treated with tunicamycin
(Group 2) compared to the normal control group (Group 1,
p<0.001 for all comparisons). Expression of all four genes
were  highest  in  Group  4  cells  (those  co-transfected  with
rAAV2- P58IPK and pGIPZ- P58IPK RNAi and treated with
tunicamycin). In contrast, expression levels of these genes in
Group 3 cells (transfected with rAAV2- P58IPK and treated
with tunicamycin) were not significantly different from those
in control cells (Group 1, Figure 3). Protein levels of ATF4,
GRP78, CHOP, and VEGF were significantly increased in the
groups treated with tunicamycin (Group 2) as well as groups
that co-transfected with rAAV2- P58IPK and pGIPZ- P58IPK
RNAi  and  treated  with  tunicamycin  (Group  4)  when
compared to the normal control group (Group 1, Figure 4).
The protein expression levels of ATF4, CHOP, and VEGF in
Group 4 cells (co-transfected with rAAV2- P58IPK and pGIPZ-
P58IPK RNAi) were also significantly higher than those in
Group 3 (transfected with rAAV2- P58IPK). No significant
differences were detected between Group 3 (transfected with
rAAV2- P58IPK and treated with tunicamycin) and Group 1
(normal  control  group)  for  these  variables  (Figure  4).
Representative western blot images are shown in Figure 5.
DISCUSSION
ER stress is known to cause apoptosis in retinal cells. In the
early stages of DR, increased expression of CHOP, GRP78,
and other factors closely correlate with apoptosis in retinal
pericytes [5]. Hence, it has been suggested that ER stress plays
a key role in the initiation and development of DR.
Figure 1. P58IPK expression in human retinal capillary endothelial
cells in different groups. A: P58IPK expression in human retinal
capillary endothelial cells (HRCECs) transfected with rAAV2-GFP,
pGIPZ-GFP,  rAAV2-  P58IPK,  and  pGIPZ-P58IPK  RNAi  as
determined  by  semi-quantitative  PCR.  There  were  significant
differences in the expression levels of P58IPK/GAPDH among the
four transfection groups (p<0.001). The highest level was in the
group transfected with rAAV2- P58IPK (0.63±0.04) while the lowest
was  in  the  group  with  pGIPZ-  P58IPK  RNAi  (0.23±0.04).  No
significant differences in P58IPK/GAPDH levels were found between
the rAAV2-GFP (0.35±0.05) and pGIPZ-GFP groups (0.41±0.04).
B: P58IPK expression in (HRCECs) transfected with rAAV2-GFP,
pGIPZ-GFP,  rAAV2-  P58IPK,  and  pGIPZ-P58IPK  RNAi  as
determined by real time PCR. There were significant differences in
the expression levels of P58IPK/GAPDH among the four transfection
groups (p<0.001). The ratio of P58IPK/GAPDH was 1.45±0.09 in the
rAAV2- P58IPK group and 0.41±0.06 in the pGIPZ- P58IPK RNAi
group. No significant differences in P58IPK/GAPDH levels were
found between the rAAV2-GFP (0.76±0.05) and pGIPZ-GFP groups
(0.72±0.05).
Molecular Vision 2008; 14:1122-1128 <http://www.molvis.org/molvis/v14/a133> © 2008 Molecular Vision
1125Taking  into  account  previously  reported  findings;  we
conducted a study of HRCECs transfected with P58IPK to
examine the effects of P58IPK on the relief of ER stress (a
mediator of diabetes and DR) and apoptosis. We found that
HRCECs  overexpressing  P58IPK  exhibited  decreased
expression of the ER stress-related factors, GRP78, ATF4,
and CHOP, following ER stress. Importantly, when P58IPK
expression was silenced by co-transfecting HRCECs with
RNAi against P58IPK, the previously noted inhibition of ER
stress was abolished i.e., expression of the aforementioned
factors were increased. These findings suggest that P58IPK
plays  an  important  role  in  maintaining  the  balance  and
stability of the ER in HRCECs.
P58IPK  is  purported  to  be  an  important  factor  in
maintaining balance within the endoplasmic reticulum [16].
In the present study, we demonstrated that when endogenous
P58IPK expression was increased by transfection, expression
of ATF4 and VEGF was decreased in HRCECs following ER
stress. Given these findings, we speculate that P58IPK has the
capacity  to  downregulate  the  activity  of  the  ATF4/VEGF
pathway during ER stress. We also noted that increased P58IPK
expression was associated with decreased CHOP expression
in HRCECs. Given that CHOP is an initiator of apoptosis, it
is hardly surprising that apoptosis levels also decreased in
Figure 2. Effect of P58IPK on apoptosis in human retinal capillary
endothelial cells s after tunicamycin-induced endoplasmic reticulum
stress.  There  was  no  significant  difference  between  groups  1
(control) and 3 (rAAV2- P58IPK). Apoptosis levels were higher than
groups 1 and 3 in group2. Apoptosis levels were significantly higher
in group 4 (co-transfected with pGIPZ- P58IPK RNAi and rAAV2-
P58IPK) compared to all other groups (p<0.001 for all). Group 1
represents  normal  control  that  was  not  endoplasmic  reticulum-
stressed. Group 2 represents human retinal capillary endothelial cells
(HRCECs) treated with tunicamycin. Group 3 represents HRCECs
transfected with rAAV2-P58IPK and treated with tunicamycin. Group
4 represents HRCECs transfected with pGIPZ-P58IPK RNAi and
treated with tunicamycin.
Figure 3. The effect of P58IPK on gene expression of ATF4, C/EBP
homologous protein, GRP78, and vascular endothelial growth factor
on human retinal capillary endothelial cells by real time PCR. A:
Evaluation the effect of P58IPK on gene expression of ATF4 on
human retinal capillary endothelial cells (HRCECs) treated with
tunicamycin by real time PCR. Group 1 is normal control that was
not  endoplasmic  reticulum  (ER)-stressed.  Group  2  is  HRCECs
treated  with  tunicamycin.  Group  3  is  HRCECs  transfected  with
rAAV2-P58IPK, and treated with tunicamycin. Group 4 is HRCECs
transfected with pGIPZ-P58IPK RNAi and treated with tunicamycin.
The  expression  level  of  ATF4  in  either  group  was:  0.52±0.05,
1.14±0.05, 0.58±0.06, and 1.54±0.06 (p< 0.001), respectively. B:
Evaluation the effect of P58IPK on gene expression of GRP78 on
HRCECs  treated  with  tunicamycin  by  real  time  PCR:  Group  1
represents  normal  control  that  was  not  ER-stressed.  Group  2
represents HRCECs treated with tunicamycin. Group 3 represents
HRCECs  transfected  with  rAAV2-P58IPK  and  treated  with
tunicamycin. Group 4 represents HRCECs transfected with pGIPZ-
P58IPK RNAi and treated with tunicamycin. The expression level of
GRP78 in either group was: 1.13±0.08, 1.96±0.14, 1.09 ±0.13, and
2.44±0.16  (p<  0.001),  respectively.  C:  Evaluation  the  effect  of
P58IPK on gene expression of C/EBP homologous protein (CHOP)
on HRCECs treated with tunicamycin by real time PCR. Group 1 is
normal control that was not ER-stressed. Group 2 is HRCECs treated
with tunicamycin. Group 3 is HRCECs transfected with rAAV2-
P58IPK and treated with tunicamycin. Group 4 is HRCECs transfected
with  pGIPZ-P58IPK  RNAi  and  treated  with  tunicamycin.  The
expression level of CHOP in either group was: 0.35±0.02, 0.61±0.03,
0.39±0.04, and 0.83±0.06 (p< 0.001), respectively. D: Evaluation the
effect of P58IPK on gene expression of vascular endothelial growth
factor (VEGF) on HRCECs treated with tunicamycin by real time
PCR. Group 1 represents normal control that was not ER-stressed.
Group 2 represents HRCECs treated with tunicamycin. Group 3
represents HRCECs transfected with rAAV2-P58IPK and treated with
tunicamycin. Group 4 represents HRCECs transfected with pGIPZ-
P58IPK RNAi and treated with tunicamycin. The expression level of
VEGF in either group was: 1.02±0.07, 1.61±0.04, 1.02 ±0.07, and
2.14±0.12 (p< 0.001), respectively.
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1126Figure 4. The effect of P58IPK on gene expression of ATF4, C/EBP
homologous protein, GRP78 and vascular endothelial growth factor
on human retinal capillary endothelial cells by western blot. A:
Evaluation the effect of P58IPK on gene expression of ATF4 on
human retinal capillary endothelial cells (HRCECs) treated with
tunicamycin by western blot: Group 1 is normal control that was not
ER-stressed. Group 2 is HRCECs treated with tunicamycin. Group
3  is  HRCECs  transfected  with  rAAV2-P58IPK  and  treated  with
tunicamycin. Group 4 is HRCECs transfected with pGIPZ-P58IPK
RNAi and treated with tunicamycin. The expression level of ATF4
in either group was: 0.12±0.03, 0.25±0.03, 0.16±0.04, and 0.33±0.04
(p< 0.001), respectively. B: Evaluation the effect of P58IPK on gene
expression  of  GRP78  on  HRCECs  treated  with  tunicamycin  by
western  blot:  Group  1:normal  control  that  was  not  endothelial
reticulum  (ER)-stressed.  Group  2  is  HRCECs  treated  with
tunicamycin. Group 3 is HRCECs transfected with rAAV2-P58IPK
and treated with tunicamycin. Group 4 is HRCECs transfected with
pGIPZ-P58IPK RNAi and treated with tunicamycin. The expression
level  of  GRP78  in  either  group  was:  0.10±0.02,  0.22±0.02,
0.12±0.03, and 0.17±0.02 (p< 0.001), respectively. C: Evaluation the
effect of P58IPK on gene expression of C/EBP homologous protein
(CHOP) on HRCECs treated with tunicamycin by western blot:
Group 1 is normal control that was not ER-stressed. Group 2 is
HRCECs treated with tunicamycin. Group 3 is HRCECs transfected
with  rAAV2-P58IPK  and  treated  with  tunicamycin.  Group  4  is
HRCECs transfected with pGIPZ-P58IPK RNAi and treated with
tunicamycin. The expression level of CHOP in either group was:
0.08±0.02,  0.18±  0.04,  0.10  ±0.03,  and  0.26±0.03  (p<  0.001),
respectively. D: Evaluation the effect of P58IPK on gene expression
of vascular endothelial growth factor (VEGF) on HRCECs treated
with tunicamycin by western blot: Group 1 is normal control that was
not ER-stressed. Group 2 is HRCECs treated with tunicamycin.
Group 3 is HRCECs transfected with rAAV2-P58IPK and treated with
tunicamycin. Group 4 is HRCECs transfected with pGIPZ-P58IPK
RNAi and treated with tunicamycin. The expression level of VEGF
in either group was: 0.06±0.01, 0.13±0.02, 0.08±0.01, and 0.17±0.02
(p< 0.001), respectively.
Figure 5. The effect of P58IPK on gene expression of ATF4, C/EBP
homologous protein, GRP78 and vascular endothelial growth factor
on human retinal capillary endothelial cells by western blot. A:
Evaluation the effect of P58IPK on gene expression of vascular
endothelial  growth  factor  (VEGF)  on  human  retinal  capillary
endothelial cells (HRCECs) treated with tunicamycin by western
blot.  Normal  represents  normal  control  that  was  not  endothelial
reticulum  (ER)-stressed;  P58IPK  represents  HRCECs  transfected
with  rAAV2-P58IPK  and  treated  with  tunicamycin  ;  ER  stress
represents  HRCECs  treated  with  tunicamycin;  RNAi  represents
HRCECs transfected with pGIPZ-P58IPK RNAi, and treated with
tunicamycin. The expression level of VEGF in either group was:
0.06±0.01,  0.08±0.01,  0.13±0.02;  and  0.17±0.02  (p<0.001),
respectively. B: Evaluation the effect of P58IPK on gene expression
of ATF4 on HRCECs treated with tunicamycin by western blot:
Normal represents normal control that was not ER-stressed; P58IPK
represents HRCECs transfected with rAAV2-P58IPK and treated with
tunicamycin  ;ER  stress  represents  HRCECs  treated  with
tunicamycin;RNAi  represents  HRCECs  transfected  with  pGIPZ-
P58IPK RNAi and treated with tunicamycin. The expression level of
ATF4 in either group was: 0.12±0.03, 0.16±0.04, 0.25±0.03, and
0.33±0.04 (p<0.001), respectively. C: Evaluation the effect of P58IPK
on  gene  expression  of  C/EBP  homologous  protein  (CHOP)  on
HRCECs  treated  with  tunicamycin  by  western  blot.  Normal
represents normal control that was not ER-stressed; P58IPK represents
HRCECs  transfected  with  rAAV2-P58IPK  and  treated  with
tunicamycin;  ER  stress  represents  HRCECs  treated  with
tunicamycin; RNAi represents HRCECs transfected with pGIPZ-
P58IPK RNAi and treated with tunicamycin. The expression level of
CHOP in either group was: 0.08±0.02, 0.10±0.03, 0.18±0.04, and
0.26±0.03  (p<  0.001),  respectively.  D:  Evaluation  the  effect  of
P58IPK  on  gene  expression  of  GRP78  on  HRCECs  treated  with
tunicamycin by western blot. Normal represents normal control that
was not ER-stressed; P58IPK represents HRCECs transfected with
rAAV2-P58IPK  and  treated  with  tunicamycin;  RNAi  represents
HRCECs transfected with pGIPZ-P58IPK RNAi and treated with
tunicamycin;  ER  stress  represents  HRCECs  treated  with
tunicamycin. The expression level of GRP78 in either group was:
0.10±0.02,  0.12±0.03,  0.22±0.02,  and  0.17±0.02  (p<0.001),
respectively.
Molecular Vision 2008; 14:1122-1128 <http://www.molvis.org/molvis/v14/a133> © 2008 Molecular Vision
1127prevent  the  process  of  retinal  vessel  damage  caused  by
upregulated VEGF expression.
In summary, to our knowledge, this is the first paper to
describe the effects of P58IPK on ER stress in human retinal
capillary endothelial cells in vitro. The results of the present
study indicate that the overexpression of P58IPK in HRCECs
can effectively ameliorate ER stress by inhibiting expressions
of  GRP78,  ATF4,  VEGF,  and  CHOP  and  decreasing
apoptosis. Further study is warranted to clarify precisely how
P58IPK  interacts  with  VEGF-biologic  pathways  during  ER
stress. Confirmation of these findings using an in vivo animal
model is also needed.
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cells  that  overexpressed  P58IPK.  With  regards  to  the
development of DR, the current findings lead us to suggest
that enhanced P58IPK expression may help to decelerate or